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1078–5Objectives. To assess the prevalence and clinical significance of elevated ankle-brachial index (ABI) in patients referred to
vascular consultation.
Design. Retrospective clinical study.
Material and methods. In 1,762 patients referred with a suspicion of peripheral arterial disease (PAD), ABI and toe
brachial index (TBI) were measured by photoplethysmography. ABI 1.3 was considered falsely elevated and
TBI< 0.60 was the diagnostic criterion for PAD.
Results. The prevalence of elevated ABI was 8.4% and that of PAD among these patients 62.2%. PAD was significantly
more prevalent among subjects with severe symptoms (rest pain, ulcers or gangrene) than in those with intermittent
claudication (83.8% and 45.3%, respectively, p< 0.001). The risk of PAD diagnosis was ten-fold (OR 10.31, 95% CI
2.07e51.30) among those with chronic renal failure, five-fold among patients with a history of smoking (OR 5.63,
95% CI 1.22e26.00) and over three-fold (OR 3.44, 95% CI 1.46e8.12) among those with coronary heart disease. The
specificities of elevated ABI threshold levels (1.3, 1.4 and 1.5) in identifying PAD were 86%, 94% and 96%, respectively,
the sensitivities being 44%, 38% and 36%, respectively.
Conclusions. The prevalence of elevated ABI in patients referred to vascular consultation is 8.4% and that of PAD among
these 62.2%. PAD is significantly more probable among those with chronic renal failure, a history of smoking and coronary
heart disease. Furthermore, the specificity of elevated ABI (1.3) in recognizing PAD is good, whereas the sensitivity is
only satisfactory.
 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Keywords: Ankle brachial pressure index; Mediasclerosis; Peripheral arterial disease.Introduction
The prevalence of peripheral arterial disease (PAD)
increases with age and affects approximately 20% of
the population over 75 years of age.1 The disorder is
associated with high cardiovascular morbidity and
mortality but remains an under-diagnosed problem
in the primary care setting.2,3 Ankle brachial pressure
index (ABI) measurement with the use of Doppler
techniques is an established non-invasive means of
diagnosing PAD. The presence of mediasclerosis,
however, may invalidate the ABI as a diagnostic
tool, as the arterial wall becomes stiffer and resists
compression, giving falsely elevated pressure values.sponding author. V. Suominen, MD, Tampere University
al, Department of Surgery, Division of Vascular Surgery,
ox 2000, 33521 Tampere, Finland.
address: velipekka.suominen@pshp.fi
884/000709+ 06 $34.00/0  2008 European Society for VasculaIn such cases, as the vessels of the toes are generally
not affected by mediasclerosis, the measurement of
great toe artery pressure for the calculation of the
toe brachial index (TBI) is commonly advocated.4e6
Unfortunately, this method is often available only in
specialized vascular units.
The problem of elevated ABI has attracted little
attention in the literature on PAD, and no uniform
ABI criterion for elevated ABI exists. While some
authors have recommended that high ABI be
suspected when ABI exceeds 1.15, others have used
cut-off values between 1.3 and 1.5.7e10 The problem
of a cut-off value is further underlined by the fact
that, especially in younger subjects, ankle pressures
normally exceed the systolic pressure of the aorta
and brachial vessels due to good arterial wall compli-
ance and strong arterial wave reflection, thus giving
a resting ABI over 1.0. Consequently, the proportion
of individuals with elevated ankle pressure variesr Surgery. Published by Elsevier Ltd. All rights reserved.
710 V. Suominen et al.between studies and its true prevalence remains
obscure. Moreover, the clinical significance of elevated
ABI is not as clear as that of low ABI. However, an
association between high ABI and total and cardio-
vascular mortality similar to that of low ABI was
found in two recently published studies.11,12
The present aims were (1) to establish the preva-
lence of elevated ankle brachial index among patients
admitted to the university hospital vascular outpa-
tient clinic for evaluation purposes; (2) to describe
the prevalence and risk factors of PAD among those
with elevated ABI; and (3) to assess the specificities
and sensitivities of different levels of elevated ABI
in identifying PAD.Material and Methods
Study population
This is a retrospective analysis of consecutive patients
referred to the vascular outpatient clinic at Tampere
University Hospital (TAUH), Finland, between April
2002 and January 2006. Patients with suspected lower
extremity arterial insufficiency were included in the
study. The reasons for referral were categorized as
(1) intermittent claudication, (2) rest pain, ulcer or
gangrene, (3) suspected combined arterial and venous
disease and (4) non-specified indication (coldness,
numbness). TAUH serves a region with roughly
470,000 inhabitants, and all vascular surgical consulta-
tions, diagnostics and procedures are carried out
exclusively at TAUH. Patients are referred to the
outpatient clinic not only from the municipal health
centres but also from regional cardiac, renal and other
units located within the TAUH district. Every patient
visit to the hospital is recorded in the central register
with the diagnosis and reason for attendance. The
purpose of the present study was to measure the
ankle brachial index (ABI) and toe brachial index
(TBI) of all new admissions (N¼ 2,237) during the
study period. The pressure measurements were
unsuccessful in 51 cases (2.3%). Cases with successful
measurements and with no prior lower extremity
vascular procedures (N¼ 1,762, 78.8%) were subjected
to further analysis.Risk factors for PAD and other co-morbid diseases
Data from the patients’ files were collected systemati-
cally by one examiner (VS). Case records provided
information on age, sex, cardiovascular risk factors
(diabetes mellitus, hyperlipidaemia, hypertension,
smoking within 5 years), cardiovascular diseasesEur J Vasc Endovasc Surg Vol 35, June 2008other than PAD (coronary heart disease [CHD],
cerebrovascular disease), respiratory disease, chronic
renal failure and systemic corticosteroid treatment in
addition to stored images. The diagnosis for each
disease was considered positive if it had been previ-
ously established at TAUH or mentioned in the
referral, or if the patient was on appropriate medica-
tion. No distinction was made between chronic renal
failure and ESRD.
Measurement of ABI/TBI and definitions
ABI and TBI were measured using the Nicolet Vaso-
Guard (Nicolet Vascular Inc, Madison, WI), a device
that allows simultaneous systolic blood pressure
measurements from upper and lower extremities by
means of photoplethysmography. Measurements
were carried out in optimal conditions (supine posi-
tion, room temperature, after resting for ten minutes)
by trained vascular nurses. Photoplehysmographic
probes were attached to the tips of the big toes, and
cuffs were placed on the arms and legs above the
ankle or at the base of the big toes. The higher of
the two simultaneously measured brachial systolic
blood pressure values was used in the analysis. As
a rule, values obtained from single ABI or TBI
measurements of good quality were used. ABI 0.9
was considered low, ABI> 0.9 or< 1.3 normal and
ABI 1.3 falsely elevated. Patients with an ABI 0.9
and/or TBI< 0.60 in either leg were regarded as
presenting with PAD. Patients with an ABI 1.3 in
both legs or in one leg, in which case the other side
had to be normal, were categorized as belonging to
the elevated ABI group. The calculations of the sensi-
tivity and specificity of different ABI threshold levels
(1.3, 1.4, 1.5) in identifying PAD were based on the
results of ABI and TBI measurements.
Review of the angiograms
For 69 patients with an elevated ankle brachial index
(N¼ 148), a digital subtraction angiography (DSA)
had been performed after the initial consultation. In
one patient the TBI was >0.60, while the rest had
a TBI< 0.60, i.e. PAD. The angiography images were
reviewed for the presence of PAD, defined as a more
than 50% narrowing of the arterial lumen in any
arterial segment of the lower extremities.
Statistical analysis
SPSS 15.0 for windows was used for statistical analy-
sis (SPSS, Chicago, IL, USA). For discrete variables,
711PAD among Patients with Elevated ABIanalyses were made with the aid of cross-tabulations
combined with c2-tests, and comparisons of means
between the two groups were carried out with the
t-test for independent samples. Logistic regression
analysis was used to calculate the likelihood of PAD
among those with elevated ABI. P-value< 0.05 was
considered statistically significant.
Results
The prevalence of elevated ABI
There were 1,041 (59.1%) men and 721 (40.9%) women
available for the analysis. The mean age in the cohort
was 69.5 11.7 years, the women being almost five
years older than the men ( p< 0.001). The main reason
for referral was intermittent claudication (N¼ 988,
56.1%), whereas 553 (31.4%) patients had more severe
symptoms (rest pain, ulcers, gangrene). For the
remaining 221 (12.6%) patients, the reason for referral
was combined arterial and venous disease; otherwise
the reason was non-specific. Men were more likely to
present with claudication ( p< 0.001) and women with
rest pain ( p¼ 0.003).
Low ABI was detected in 1,139 (64.6%) patients;
475 (27.0%) had normal and 148 (8.4%) elevated
ABI. The distribution was not affected by sex. The
prevalence of low ABI, i.e. PAD, increased steadily
with the age of the patients, while the prevalence of
high ABI was not dependent on age (Fig. 1). The
prevalence of cardiovascular risk factors and other0
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Fig. 1. The distribution of ABIco-morbid conditions as well as systemic corticoste-
roid treatment between the ABI categories is
presented in Table 1.
The prevalence of PAD among patients
with elevated ABI
Of the 148 patients presenting with an elevated ABI,
92 (62.2 %) were consequently considered to have
PAD. Evaluation of the DSA images confirmed the
diagnosis in all 68 available cases. The mean age of
patients with PAD was 69.6 12.4 years and of those
without PAD 68.9 11.6 years ( p¼ 0.621). A non-
significant increase in the prevalence of PAD was
observed in the older age groups (60% among those
below the age of 55 years and 80% among those
over 85 years of age, p¼ 0.741). PAD was significantly
more prevalent among subjects with severe symptoms
than among those referred due to intermittent claudi-
cation (83.8% and 45.3%, respectively, p< 0.001).
According to the logistic regression model, there
was a more than ten-fold risk of being diagnosed
with PAD among patients with chronic renal failure,
five-fold risk among those with a history of smoking
and more than three-fold risk among those with
CHD (Table 2). The presence of hyperlipidaemia
seemed to have a protective effect against PAD (OR
0.3, p¼ 0.022). However, 22 (84.6%) of the 26 patients
with hyperlipidaemia were receiving statin treatment.
As 56 patients with an elevated ABI did not have
PAD according to the TBI measurements, we further75-84 (N=591)
ge
 (N=487) 85 (N=118)IV
categories according to age.
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Table 1. The prevalence of cardiovascular risk factors and co-
morbid conditions depending on ABI level (N[ 1762)
Measure ABI 0.9 0.9<ABI< 1.3 ABI 1.3 P-
value
N¼ 1139
(%)
N¼ 475
(%)
N¼ 148
(%)
Diabetes mellitus 380 (33) 147 (31) 73 (49) <0.001
Hyperlipidaemia 318 (28) 129 (27) 26 (18) 0.028
Hypertension 604 (53) 210 (44) 64 (43) 0.001
Smoking 374 (33) 76 (16) 15 (10) <0.001
CHD 397 (35) 134 (28) 57 (39) 0.014
Cerebrovascular
disease
122 (11) 43 (9) 12 (8) 0.429
Respiratory
disease
140 (12) 36 (8) 18 (12) 0.020
Renal failure 67 (6) 29 (6) 21 (14) 0.001
Systemic
corticosteroid
treatment
39 (3) 19 (4) 20 (14) <0.001
712 V. Suominen et al.assessed the validity of different elevated ABI levels
(1.3, 1.4 and 1.5) in identifying PAD. The prevalence
of PAD was 78.2% (79/101) among subjects with an
ABI> 1.4 and 83.5% (76/91) among those with an
ABI> 1.5. Of the 475 patients with normal ABI, 118
(24.8%) had a TBI< 0.6. By pooling the normal and
elevated ABI groups, i.e. all subjects with an ABI>
0.9 (N¼ 623), and then defining the number of pa-
tients in the combined groups who had a TBI< 0.6
(N¼ 210), we were able to determine the respective
specificities and sensitivities. The specificities were
good, with a tendency to increase with elevation of
the threshold level (86%, 94% and 96%, respectively),
whereas the sensitivities were only satisfactory (44%,
38% and 36%, respectively).Discussion
According to our findings, the prevalence of elevated
ABI among patients referred to the vascularTable 2. The odds of being diagnosed with PAD among those with
elevated ABI (N[ 148)*
Measure OR 95%CI
Diabetes 1.66 0.76e3.63
Hyperlipidaemia 0.30 0.11e0.84
Hypertension 0.72 0.33e1.57
Smoking 5.63 1.22e26.00
CHD 3.44 1.46e8.12
Cerebrovascular disease 1.32 0.34e5.17
Respiratory disease 1.47 0.46e4.70
Renal failure 10.31 2.07e51.30
Systemic corticosteroid treatment 1.87 0.55e6.30
Sex (male) 1.77 0.75e4.22
Age (per 10 years) 1.26 0.89e1.80
Dependent factor: PAD according to the angiographic findings and
TBI.
* Logistic regression model.
Eur J Vasc Endovasc Surg Vol 35, June 2008outpatient clinic was 8.4%, which was not affected
by age or sex. The prevalence of PAD among those
with elevated ABI was 62.2%. A significant associa-
tion between PAD and clinical signs of critical limb is-
chemia (rest pain, ulcer, gangrene) as compared to
claudication was observed at presentation. Further-
more, we found a significant likelihood of being diag-
nosed with PAD among subjects with chronic renal
failure, a history of smoking and CHD. Our results
also suggest that the specificity of elevated ABI
(1.3) in recognizing PAD is good, whereas the sensi-
tivity remains not more than satisfactory.
The prevalence of PAD has been evaluated in sev-
eral epidemiological studies, falling within the range
of 3%e10% and increasing to 20% in persons over
75 years.1 PAD, regardless of the symptoms, has
been associated with increased cardiovascular mor-
bidity and mortality.1,13,14 Therefore, the control of
cardiovascular risk factorsdincluding hypertension,
hyperlipidaemia and platelet antiaggregation medica-
tiondis important in this population. Unfortunately,
only roughly one third of PAD patients exhibit typical
symptoms, and the majority are asymptomatic.2,15,16 It
is therefore vital that the general practitioner (GP) is
able to diagnose asymptomatic disease, which can
only be estimated by means of non-invasive measure-
ments, i.e. ABI measurement. A resting ABI of 0.9 is
caused by haemodynamically significant arterial
stenosis and is most often used in epidemiological
studies as a threshold value for the presence of PAD.16
Ankle pressures and, consequently, ABI can be
falsely elevated due to the use of a too narrow cuff
or due to mediasclerosis, which complicates clinical
decision-making and PAD diagnosis. In the case of
the cuff size, the problem can be avoided by using
cuffs that are at least 120% of the diameter of the mea-
suring site.4,17 If appropriately sized cuffs are used
but ABI still remains high, mediasclerosis should be
suspected, in which case the measurement of TBI is
recommended to diagnose possible PAD.4-6 In the
current study, we used the American College of Car-
diology and the American Heart Association (ACC/
AHA) recommendations for elevated (noncompress-
ible vessel) ABI, i.e.  1.3.18 For TBI, values< 0.6
have been recommended and used as a threshold
for PAD.8,19 The measurement of toe pressure, how-
ever, is more time-consuming and technically difficult
with the additional equipment required, involving
pitfalls of its owndfor example, the small vessels of
the toes are prone to vasospasm.20
The prevalence of elevated ABI varies significantly
depending on the study design and threshold values
used. Furthermore, these patients are often excluded
from studies on PAD and the clinical importance of
713PAD among Patients with Elevated ABIelevated ABI thus remains unclear. In 1968 Carter
found the incidence of lower extremity vessel incom-
pressibility to be only 1% in a series of 600 limbs
studied.21 In more recent publications, the prevalence
has ranged from less than 1% to up to 13.6%, and even
higher among diabetic patients.1,7,10,22 Our results,
with a 12.2% prevalence of elevated ABI among
diabetic patients versus 6.5% among those without
the disease, support this general impression. Two of
the aforementioned studies were population-based
with a cut-off value of >1.5, which may explain the
low prevalence. The material in our study comprised
selected patients referred to a vascular surgical unit
due to lower limb symptoms and does not represent
the whole population. This may also explain the
difference in prevalence compared to the results
obtained by groups under Diehm and Meijer. Our
findings are in line with previous results suggesting
that chronic renal failure and systemic corticosteroid
treatment are associated with elevated ABI.8,9 On the
other hand, contrary to what has been stated
elsewhere,5,9,23 the prevalence of high ABI was not
affected by age.
Since TBI measurement is often available only in
specialized vascular units, it would be desirable to
have clinical evidence and findings to guide clinicians
as to when to suspect PAD among patients with
elevated ABI. Our results suggest that elevated ABI
itself is markedly associated with PAD and that the
specificity increases with the elevation of the ABI
values. Furthermore, PAD should be suspected
among patients with high ABI combined with chronic
renal failure, a history of smoking, CHD and severe
lower extremity symptoms. Unfortunately, however,
our results show that normal ABI does not exclude
the possibility of PAD. This is contradictory to what
has been proposed by Brooks and associates regard-
ing the necessity of TBI measurements among subjects
with elevated ABI.24 The large number of patients
with normal ABI but pathological TBI in the current
material is probably explained by a moderate incom-
pressibility of arteries and, thus, normal ABI in some
individuals, even though they actually have poor flow
at the ankle level. This reflects the clinical design of
the study and is supported by the angiographic data
available confirming the diagnosis of PAD in 44 out
of 47 patients. This would render the other possible
explanation, i.e. technical errors in measuring ABI
and TBI, less likely and thus enhances confidence in
our sensitivity and specificity calculations. Neverthe-
less, if vascular surgical consultation is, for any
reason, not required or planned, the aforementioned
findings should be taken into consideration when
planning risk factor management for the particularpatient. This is further emphasized by the fact that el-
evated ABI is associated with significant cardiovascu-
lar and total mortality, similarly to low ABI.11,12 In
fact, we believe that our results may even partly
explain why such an association exists. Interestingly,
however, hyperlipidaemia seems to have a protective
effect against PAD. The widespread use of statins
accompanied by a reduced intima-media thickness
at the carotid and femoral level may explain this
effect.25 The relatively low prevalence of hyperlipi-
daemia in the present study, probably owing to the
study design, reduces the value of this finding.
The device used to measure ABI and TBI in the
current study is in clinical use worldwide and has
also been employed for research purposes.8 However,
a PubMed search produced no mention of studies on
the test-retest reproducibility or validity of this
particular equipment. In general terms, pressure
measurements have been shown to be reasonably
reproducible in previous studies, especially when per-
formed by trained personnel.26,27 In our institution,
the method and device have been used for the past
ten years and measurements are undertaken exclu-
sively by trained vascular nurses.
There are several limitations to our study, the main
drawback being the retrospective design involving
possible data issues associated with the use of
hospital discharge histories and patient case records.
Consequently, miscoding and lack of clinical informa-
tion may cause uncertainty in the results. However,
the multiple admissions of the subjects to our hospital
due to co-morbidities prior to the initiation of the
current study made data collection easier and, we
believe, more accurate. Furthermore, possible data
errors and miscoding will be similar for all groups.
The second limitation is the clinical nature of the
study, with a relatively high prevalence of elevated
ABI. This certainly affects any generalization of the
present results, especially in terms of the general
population.Conclusions
According to our findings made in a clinical setting,
the prevalence of elevated ABI is 8.4%. The prevalence
of PAD among patients with elevated ABI is 62.2%,
and it is significantly more probable among those
with chronic renal failure, a history of smoking and
CHD. Furthermore, our study confirms the high prev-
alence of PAD among patients with severe lower leg
symptoms and high ABI. The specificity of elevated
ABI (1.3) in identifying patients with PAD seems
to be good, whereas its sensitivity in excluding theEur J Vasc Endovasc Surg Vol 35, June 2008
714 V. Suominen et al.disease is only satisfactory. These findings may pro-
vide guidance in clinical decision-making associated
with this problem, especially in patients with chronic
renal failure. Further studies are warranted to deter-
mine a generally acceptable cut-off value and thereby
the true prevalence and significance of elevated ABI.References
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